Direct Acting Antivirals Which Is Effective in Pan-genotypic Chronic Hepatitis C Patients with or without Liver Cirrhosis

Direct Acting Antivirals Which Is Effective in Pan-genotypic Chronic Hepatitis C Patients with or without Liver Cirrhosis

Articles: Sofosbuvir and Velpatasvir for HCV Genotype 1, 2, 4, 5, and 6 Infection (N Engl J Med 2015;373:2599-2607) Sofosbuvir and Velpatasvir for HCV Genotype 2 and 3 Infection (N Engl J Med 2015;373:2608-2617)

Bibliographic Details
Main Author:	Ki Tae Yoon
Format:	Article
Language:	English
Published:	Jin Publishing & Printing Co. 2016-10-01
Series:	The Korean Journal of Gastroenterology
Online Access:	http://www.kjg.or.kr/journal/view.html?doi=10.4166/kjg.2016.68.4.229

Similar Items

Effect of different direct-acting antivirals on the clinical outcome of genotype 1b chronic hepatitis C and compensated hepatitis C cirrhosis
by: HOU Yihui
Published: (2020-01-01)

THE EVOLUTION OF LIVER FIBROSIS AFTER THE TREATMENT WITH DIRECT-ACTING ANTIVIRAL AGENTS IN HEPATIC CIRRHOSIS: EXPERIENCE OF A CENTER
by: Mariana Avricenco, et al.
Published: (2020-10-01)

Liver function following hepatitis C virus eradication by direct acting antivirals in patients with liver cirrhosis: data from the PITER cohort
by: Maria Giovanna Quaranta, et al.
Published: (2021-05-01)

P-55 QUALITY OF LIFE IMPROVES IN PATIENTS WITH OR WITHOUT CIRRHOSIS AFTER HEPATITIS C CURE WITH DIRECT-ACTING ANTIVIRAL AGENTS
by: Lucrecia Garcia Olveira, et al.
Published: (2021-09-01)

Impact of hepatitis C virus genotype-4 eradication following direct acting antivirals on liver stiffness measurement
by: Tag-Adeen M, et al.
Published: (2017-10-01)

Refractory Hepatic Hydrothorax in Chronic Hepatitis C Controlled by Direct-acting Antivirals
by: Myung Hee Kim, et al.
Published: (2020-02-01)

Direct-acting antivirals: a new strategy in the treatment of hepatitis C virus infection in patients with cirrhosis
by: Mariana Avricenco
Published: (2019-12-01)

Resolution of refractory hepatic hydrothorax in patients with hepatitis C virus cirrhosis after treatment with direct-acting antiviral agents
by: Maged H Hussein, et al.
Published: (2018-01-01)

Direct Acting Antivirals for the Treatment of Chronic Viral Hepatitis
by: Peter Karayiannis
Published: (2012-01-01)

Viral dynamics among HCV infected patients with different genotypes treated with genotypic specific or pan-genotypic direct-acting antiviral agent combinations
by: Paolucci S, et al.
Published: (2019-07-01)

ANTIVIRAL THERAPY IN LIVER CIRRHOSIS
by: P. O. Bogomolov, et al.
Published: (2016-02-01)

Treatment of hepatitis C virus genotype 3 infection with direct-acting antiviral agents
by: L.P. Zanaga, et al.

EFFECT OF ANTIVIRAL THERAPY ON CARDIOHEMODYNAMIC INDICATORS IN PATIENTS WITH CHRONIC VIRAL HEPATITIS AND LIVER CIRRHOSIS
by: M. V. Chistyakova, et al.
Published: (2017-01-01)

Atherosclerosis in chronic hepatitis C virus patients with and without liver cirrhosis
by: Ashraf Abd El-Khalik Barakat, et al.
Published: (2017-06-01)

Comparing the Efficacy of Direct Acting Antiviral Agents for the Treatment of Hepatitis C Virus Genotype 1
by: Ali, Rahma, et al.
Published: (2016)

Economic evaluation of direct‐acting antivirals for the treatment of genotype 3 hepatitis C infection in Singapore
by: Yu‐Jun Wong, et al.
Published: (2019-06-01)

Direct-Acting Antiviral Therapy in Liver Transplant Patients With Hepatocellular Carcinoma and Hepatitis C
by: Chung Sang Tse, et al.
Published: (2021-01-01)

Direct Acting Antivirals for Treatment of Hepatitis C Infection in Patients with Advanced Liver Disease
by: Woo Jin Chung
Published: (2016-01-01)

Association of direct-acting antiviral therapy for hepatitis C with the development and recurrence of liver cancer
by: LI Yan
Published: (2018-02-01)

Direct Acting Antivirals in Patients with Chronic Hepatitis C and Down Syndrome
by: Eric R. Yoo, et al.
Published: (2016-01-01)

Effects of Age on Treatment of Chronic Hepatitis C with Direct Acting Antivirals
by: Alexandre Pariente, et al.
Published: (2019-01-01)

The efficacy of direct-acting antiviral therapy in patients with chronic hepatitis C
by: Irina RUSU, et al.
Published: (2020-03-01)

Systematic Review with Meta-Analysis: Efficacy and Safety of Direct-Acting Antivirals for Chronic Hepatitis C Genotypes 5 and 6
by: Ong The Due, et al.
Published: (2019-01-01)

New treatment of hepatitis C (Direct Acting Antiviral)
by: Mohsen Akhondi-Meybodi
Published: (2019-10-01)

Effect of Direct-Acting Antiviral Therapy on Thrombocytopenic Patients with Hepatitis C Virus-Related Chronic Liver Disease
by: Mahmoud Saif-Al-Islam, et al.
Published: (2021-01-01)

Antiviral therapy in chronic Hepatitis C virus-related decompensated liver cirrhosis - A tightrope walk
by: Amarapurkar Deepak
Published: (2010-01-01)

Antiviral treatment in patients with hepatitis C virus-related cirrhosis awaiting liver transplantation
by: Pierluigi Toniutto, et al.
Published: (2008-06-01)

Comparison of the efficacy and safety of direct-acting antiviral therapy with or without hepatitis C-related hepatocellular carcinoma
by: Byung Soo Kwan, et al.
Published: (2021-03-01)

Decreased Incidence of Hepatocellular Carcinoma after Directly Acting Antiviral Therapy in Patients with Hepatitis C–Related Advanced Fibrosis and Cirrhosis
by: Kilany S, et al.
Published: (2021-08-01)

Real-World Results of Direct-Acting Antiviral Agents for Chronic Hepatitis C
by: Chun-Ming Hong, et al.
Published: (2018)

Impact of treatment with direct-acting antivirals on anxiety and depression in chronic hepatitis C.
by: Marta Gallach, et al.
Published: (2018-01-01)

Treatment of chronic viral hepatitis C with direct acting antiviral agent: review
by: V A Malov, et al.
Published: (2019-11-01)

Unmet needs of chronic hepatitis C in the era of direct-acting antiviral therapy
by: Chung-Feng Huang, et al.
Published: (2020-07-01)

Mechanism of action of direct-acting antiviral agents in treatment of chronic hepatitis C
by: WEN Xiaoyu, et al.
Published: (2016-09-01)

Drug-drug interaction of direct-acting antivirals in treatment of chronic hepatitis C
by: WANG Menglan
Published: (2018-02-01)

Direct-acting antivirals for patients with chronic hepatitis C and hepatocellular carcinoma in Taiwan
by: Chen-Ta Chi, et al.
Published: (2021-06-01)

Barriers to treatment of chronic hepatitis C with direct acting antivirals in an urban clinic
by: Miguel Malespin, et al.
Published: (2019-03-01)

Liver-related events and mortality among elderly patients with advanced chronic hepatitis C treated with direct-acting antivirals.
by: Iria Rodríguez-Osorio, et al.
Published: (2019-01-01)

Status of liver stiffness following directly acting antiviral treatment in patients with chronic hepatitis C: A Nepalese study
by: Dilip Sharma, et al.
Published: (2017-10-01)

Non-invasive quantification of liver fibrosis regression following successful treatment of chronic hepatitis C with direct acting antivirals
by: Nițescu Maria, et al.
Published: (2017-10-01)